Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A thallium ion chelator is a synthetic or natural ligand designed to tightly and selectively bind thallium ions (Tl⁺ or Tl³⁺). These molecules utilize donor atoms—often nitrogen and oxygen in specific geometric arrangements—to form stable coordination complexes that sequester thallium, reducing its toxic potential or facilitating its use in radiolabeling (such as Thallium-201 for nuclear imaging)[1][3][4][5]. Numerous chemical scaffolds have been explored, including cryptands such as Kryptofix-222, tropolone derivatives like tropolonate and hinokitiolate, and polyaminopolycarboxylic acids like pypa. Chelators are evaluated for their binding strength, selectivity, and ability to function under physiological conditions. They are not biological macromolecules, receptors, enzymes, or transporters but play a critical role in toxicology, radiochemistry, and diagnostic medicine[1][3][4][5].
Chemical chelation: Formation of stable complexes with thallium ions through coordination of electron-donor atoms (N, O), effectively trapping and neutralizing the metal ion to facilitate excretion or allow safe use in diagnostic nuclear medicine
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thallium ion chelator (None).